;;This file contains all the raw data input into the model that is common for all people (global variables)

globals 
[
 ;not used
  InititalINfections
  FinalINfections 
  count1
  count2
  numACTStable3
  numTranstable3
  numActsCasualMSM
  numActsMainMSM
  numActsConMSM
  numActsMainHET
  numActsConHET
  
 ; initial-infection-percent
  
 ;model specific variables, tracking time and common variable length 
  t-start
  sim-dry-run
  tempRun
  maxTicks
  maxYear
  caliMax
  caliRun
  
  num-sex
  num-age
  num-stage
  num-CD4
  length-of-partner-distribution
  length-of-linked-to-care
  length-of-partner-type
  age-group
  PLWH   
  age-UB
  age-LB
  CD4-UB
  CD4-LB
  
 ;intermediate variables trakcing transmission rate and prevalence
  count-trans-by-stage
  count-trans-by-sex
  count-trans-by-age
  count-trans-by-partner-type  
  count-person-years-by-stage
  count-person-years-by-sex
  count-person-years-by-age
  prevalence
  sharing-prevalence
  IDU-prevalence
  IDU-sharing-prevalence
  total-transmissions
  total-transmissions-quarter
  population-time-on-salvage
  population-time-on-ART
  population-life-with-infection
  zero-on-salvage
  population-no-life-lost-from-infection
  population-die-from-CD4-zero
  countNewDiagnosis
  total-people
  total-sharing
  total-people-sex
  partners-per-month
  
 ;sensitivity analysis
  sensitive-var-name
  num-sensitive-var
  base-var-val
  base-var-table
  sensitive-var-table
  sensitive-range
  num-sensitive-range 
  
 ;initialization variables for 2006 data
  pop-by-age
  factor
  overall-prevalence
  perc-HET-FEM
  perc-HET-MEN
  perc-MSM
  perc-IDU-FEM
  perc-IDU-MEN
  perc-IDU-MSM
  num-HET-FEM
  num-HET-MEN
  num-MSM
  num-IDU-FEM
  num-IDU-MEN
  num-IDU-MSM
  
  sex-dist-target
  sex-dist-before
  sex-dist-after
  cum-sex
  cum-stage 
  cum-age1
  cum-age2  
  prop-unaware-new
  prop-MSM-stage3-new
  prop-MSM-stage4-new
  actual-age-dist-PLWH
 
 ;viral load and CD4 data
  viral-load-by-stage-mean
  viral-load-by-stage-lb
  viral-load-by-stage-ub
  viral-load-by-stage-std
  viral-load-salvage-add-mean
  viral-load-salvage-AIDS-add-mean
  viral-load-salvage-add-lb
  viral-load-salvage-AIDS-add-lb
  viral-load-salvage-add-ub
  viral-load-salvage-AIDS-add-ub
  viral-load-salvage-add-std
  
  CD4-decline
  CD4-decline-upper-bound-month 
  CD4-decline-lower-bound-month 
  CD4-decline-std-month 
  CD4-decline-quarter
  
  CD4-increment-1
  CD4-increment-2
  CD4-increment-3
  CD4-max-levels
  
  CD4-start-ART-guideline
  CD4-start-ART-guideline1
  CD4-start-ART-guideline2
  CD4-start-ART-guideline3
  CD4-count-stratum 
  
  CD4-upper-new-infection
  CD4-lower-new-infection
  unaware-CD4-upper
  unaware-CD4-lower
  unaware-CD4-prob
  awareNoCare-CD4-lower
  awareNoCare-CD4-upper
  inCareNoART-CD4-lower
  inCareNoART-CD4-upper
  inCareNoART-CD4-prob
  ART-CD4-lower
  ART-CD4-upper
  CD4-at-ART-lower
  CD4-at-ART-upper
  CD4-at-ART-prob
  
  prop-CD4-diagnosis-500
  prob-CD4-diagnosis-200
  prob-CD4-diagnosis-50
  prob-CD4-at-care-200
  
 ;regimen and dropout
  rebound-duration
  viral-rebound-rate
  viral-rebound-CD4-upper
  viral-rebound-CD4-lower
  viral-rebound-increase
  probability-initial-suppression
  num-regimen
  initial-drop-out
  prob-reEnter
  
 ;IDU related variables
  percent-IDU-sharing
  percent-needles-shared 
  prob-ptnr-sharing
  dry-run-prob-ptnr-sharing
  percent-sharing-decline
  
  max-ptnr
  num-needles-max
  num-needles-min
  reduction-aware-needles 
  reduction-ART-needles
  reduction-noART-needles
  reduction-VLS-needle-trans-rate
  IDU-mixing 
  
 ;OI and death variables
  OI-probabilities
  death-prob-sexual-no-AIDS
  death-prob-sexual-AIDS
  death-prob-idu-no-AIDS
  death-prob-idu-AIDS 
  death-rate-no-ART-sexual
  death-rate-no-ART-idu
  define-non-AIDS-death
  
  ; transmission rate probabilities
  trans-rate-prob
  trans-rate-prob-stage
  trans-rate-needle
  trans-rate-needle-dry-run
  trans-rate-needle-after-dry-run
  acute-rate-increase-base
  acute-rate-increase-week
  acute-rate-increase-week-MSM
  acute-rate-increase-week-HET
  reduction-VLS-trans-rate
  
 ;testing variables
  freq-MSM
  freq-HET
  freq-at-least-once
  freq-no-test
  prob-compliance
  prob-no-test
  
 ;cost variables
  discount-rate
  HIV-utilization-cost ;; inpatient + outpatient + ED costs: incurred from start of care for HIV
  non-HIV-med-cost ;; non-HIV medication costs : incurredd from time of infection
  std-not-in-care-cost  ;;non-HIV-med-cost
  std-in-care-cost ;; non-HIV-med-cost + inpatient + outpatient + ED 
  cost-testing
  retention-care-cost
  regimen-cost 
  OI-cost  
  CD4+rna-test-cost  
  HIV-genotype-test-cost
  
 ;sexual partnerships and behaviors
  age-partner-dist
  main-partners
  no-partners
  prob-casual
  prob-casual-only
  prop-concurrency
  concurrency-lambda
  prob-serosorting
  prob-bisexual 
  
  age-sex-acts
  num-sex-acts-upper
  num-sex-acts-lower
  prop-anal-acts-HET
  condom
  condom-use-HET
  condom-use-MSM
  condom-100perc
  age-condom-use-MSM
  reduction-unprotected-aware
;  prep-effectiveness
;  prep-cov-casual
;  prep-cov-positive
;  prep-cov-concurrent
  
 ;PLWH by care continuum and incidence by age distribution
 ; base-case-nocare
 ; base-case-ART
 ; base-case-unaware
  
  current-unaware
  current-no-care
  current-care-noART
  current-ARTsuppressed
  care-at-diag
  care-at-diag-ByAge
  actual-age-dist-incidence
  
  matrix_unaware
  matrix_nocare
  matrix_careNoART
  matrix_ARTVLS
  matrix_LinkageToCare
  matrix_LinkageToCare_ByAge
  matrix_ageDistIncidence
  
 ;output variables related to number of partners
  medianNumPtnrs
  minNumPtnrs
  maxNumPtnrs
  meanNumPtnrs
  medianNumPtnrsMSM
  minNumPtnrsMSM
  maxNumPtnrsMSM
  meanNumPtnrsMSM
  medianNumPtnrsHET
  minNumPtnrsHET
  maxNumPtnrsHET
  meanNumPtnrsHET
  
  numByPtnrs
  percByPtnrs
  numByPtnrsMSM
  percByPtnrsMSM
  numByPtnrsHET
  percByPtnrsHET
  percByPtnrsMSM1

  percByMain
  percByConcrt  
  percByCasual
  percByMainMSM
  percByConcrtMSM
  percByCasualMSM
  percByMainHET
  percByConcrtHET
  percByCasualHET
  
  numPtnrsByCareCont
  numPtnrsByCareContMSM
  numPtnrsByCareContHET
  
 ;output variables related to PLWH
  numBySex
  percBySex
  numByStage
  percByStage
  
  numByAge 
  percByAge
  
  totalCost
  utilizationCost
  regimenCost
  OICost
  careServiceCost
  testingCost
  
  linkedToCare
  
 ;output variables related to new infections
  
  zAlpha
  numNewInfBYSex
  numNewInfViaSex
  percNewInfBySex
  percNewInfViaSex
  numNewInfViaStage
  percNewInfViaStage
  personYearsBySex
  transRateBySex
  personYearsByAge
  transRateByAge
  personYearsByStage
  transRateByStage  
  numNewInfByPtnrType
  overallTransRate
  
  numNewInfByCD4
  percNewInfByCD4
  numMSMByCD4
  percMSMByCD4
  numHETByCD4
  percHETByCD4
  
  numNewInfByAge
  numNewInfViaAge
  percNewInfByAge
  percNewInfViaAge
  
  countCD4Diag
  meanCD4Diag
  medianCD4Diag
  countCD4DiagMSM
  meanCD4DiagMSM
  medianCD4DiagMSM
  countCD4DiagHET
  meanCD4DiagHET
  medianCD4DiagHET
  
  acuteByCD4
  nonAcuteByCD4
  awareByCD4
  inCareByCD4
  onARTByCD4
  reboundByCD4
  salvageByCD4
  VLSByCD4
  
  countCD4ART
  meanCD4ART
  medianCD4ART
  countCD4ARTMSM
  meanCD4ARTMSM
  medianCD4ARTMSM
  countCD4ARTHET
  meanCD4ARTHET
  medianCD4ARTHET
  
  ; output
  rowSum
  rowSum1
  rowSum2
  rowSum3
  rowSum4
  rowSum5
  rowSum6
  rowSum7
]


;;updates prevalence every year;; 
to count-num-HIV  
  
  set total-people people with [dead = 0 and infected? = true]
  set prevalence replace-item 0 prevalence (count total-people with [sex = 1] / num-HET-FEM)
  set prevalence replace-item 1 prevalence (count total-people with [sex = 2] / num-HET-MEN)
  set prevalence replace-item 2 prevalence (count total-people with [sex = 3] / num-MSM)
  set prevalence replace-item 3 prevalence (count total-people with [sex = 4] / num-IDU-FEM)
  set prevalence replace-item 4 prevalence (count total-people with [sex = 5] / num-IDU-MEN)
  set prevalence replace-item 5 prevalence (count total-people with [sex = 6] / num-IDU-MSM)
 
end

to count-num-sharing-HIV
  
  set total-sharing people with [dead = 0 and infected? = true and needle-sharing? = true]
  if percent-IDU-sharing > 0
  [
    set sharing-prevalence replace-item 0 sharing-prevalence (count total-sharing with [sex = 1] / num-HET-FEM / percent-IDU-sharing)
    set sharing-prevalence replace-item 1 sharing-prevalence (count total-sharing with [sex = 2] / num-HET-MEN / percent-IDU-sharing)
    set sharing-prevalence replace-item 2 sharing-prevalence (count total-sharing with [sex = 3] / num-MSM / percent-IDU-sharing)
    set sharing-prevalence replace-item 3 sharing-prevalence (count total-sharing with [sex = 4] / num-IDU-FEM / percent-IDU-sharing)
    set sharing-prevalence replace-item 4 sharing-prevalence (count total-sharing with [sex = 5] / num-IDU-MEN / percent-IDU-sharing)
    set sharing-prevalence replace-item 5 sharing-prevalence (count total-sharing with [sex = 6] / num-IDU-MSM / percent-IDU-sharing)
    set IDU-sharing-prevalence (count total-sharing with [sex >= 4] / (num-IDU-FEM + num-IDU-MEN + num-IDU-MSM) / percent-IDU-sharing)
  ]
  
end
 
to update-stage-props [i]
  
  set current-unaware matrix:get-row matrix_unaware i
  set current-no-care matrix:get-row matrix_noCare i
  set current-care-noART matrix:get-row matrix_careNoART i
  set current-ARTsuppressed matrix:get-row matrix_ARTVLS i
  set care-at-diag matrix:get-row matrix_LinkageToCare i
  set care-at-diag-ByAge matrix:get-row matrix_LinkageToCare_ByAge i
  
end

;;proportion in stage changes between 2006 and 2008 (based on cascade of care)
;to update-stage-props
;  set care-at-diag care-at-diag * 1;1.005 
;  let i 0
;  let val 0
;  let change [0.007184219  0.00924733  0.006697563 0 0 0]
;  while [i < 3]
;  [
;    set val (item i current-unaware) - (item i change * 2);/ time-unit) 2008 values
;    set current-unaware replace-item i current-unaware val
;    set i i + 1
;  ]
;  ;  
;  
;  set current-no-care current-no-care * 1;0.995
;  set current-care-noART current-care-noART - (0.056169257 * 2);/ time-unit) 2008 values
;  set current-ARTsuppressed current-ARTsuppressed + (0.044579416 * 2 ); / time-unit) 2008 values
;  
;  ;set prop-unsuppressed prop-unsuppressed * 1
  
;end    

;;proportion in stage changes to achieve NHAS goals by 2015
;;either achive in 5 years 2011 to 2015 or 3 years 2013 to 2015;; uncomment as needed
;to update-stage-props-inter
; ; set goal 5
; ifelse goal < 4
;  [set care-at-diag care-at-diag * 1];1.005 ]
;  [set care-at-diag care-at-diag + ((.85 - .77) / 5) / 12 ]
;  let i 0
;  let val 0
;  let tot-unaware 0
;  
;  let change  [0 0 0 0 0 0] 
;  if goal = 2 or goal = 5
;  [set change  [0.019466421  0.029954914  0.024275862 0 0 0]];; change in 5 years
; ; [set change  [0.032444036  0.049924857  0.04045977 0 0 0]];; change in 3 years
;  while [i < 3]
;  [
;    set base-case-unaware replace-item i base-case-unaware ((item i base-case-unaware) - (item i change / time-unit))
;    set current-unaware replace-item i current-unaware (item i base-case-unaware)
;   ; set tot-unaware tot-unaware + (count people with [infected? = true and dead = 0 and sex = i] * item i current-unaware)
;    set i i + 1
;  ]
;  ;  
;  
;  ;;change in 5 years
;  
;   set tot-unaware count people with [infected? = true and dead = 0 and stage <= 2]
;   if goal <= 2 [set val 0]
;   if goal = 3 [set val 0.0575 ];0.045999894]
;   if goal = 4 [set val 0]; 0.031999894]
;   if goal = 5 [set val 0.0575] ;0.075999894]
;   
;   
;   ;;change in 3 years 
;;   set tot-unaware count people with [infected? = true and dead = 0 and stage <= 2]
;;   
;;   if goal <= 2 [set val 0]
;;   if goal = 3 [set val 0.07666649]
;;   if goal = 4 [set val 0.053333156]
;;   if goal = 5 [set val 0.12666649]
;  set base-case-nocare base-case-nocare - (val / time-unit);(0.077999894 / time-unit); goal 2= 0; goal 3= 0.058 goal 4= 0.042 goal 6 
;   
;   ;;change in 5 years
;    if goal <= 2 [set val 0]
;   if goal = 3 [set val 0.048656044]
;   if goal = 4 [set val 0.037456076]
;   if goal = 5 [set val 0.072655976]
;   
;    ;;change in 3 years 
;;  if goal <= 2 [set val 0]
;;   if goal = 3 [set val 0.081093407]
;;   if goal = 4 [set val 0.062426794]
;;   if goal = 5 [set val 0.121093293]
;  set base-case-ART base-case-ART + (val / time-unit);(0.074255971 / time-unit);;goal 2= 0; goal 3= 0.049 goal 4= 0.036 goal 6 
;  
;  set current-no-care base-case-nocare * (1 - (tot-unaware / count people with [infected? = true and dead = 0])) 
;  if goal <= 2 [set val 0.06]
;  if goal > 2 [set val 0]
;  set current-care-noART val * (1 - (tot-unaware / count people with [infected? = true and dead = 0])) ;;0.06 for goals 1 to 4; Goal 6 = 0
;  set current-ARTsuppressed base-case-ART * (1 - (tot-unaware / count people with [infected? = true and dead = 0]))
;  
;  ;set prop-unsuppressed prop-unsuppressed * 1
;   
;end   

to setup-intermediate-globals
  
  set count1 0
  set count2 0
  set numACTStable3 n-values num-stage [0]
  set numTranstable3 n-values num-stage [0]
  set numActsCasualMSM 0
  set numActsMainMSM 0
  set numActsConMSM 0
  set numActsMainHET 0
  set numActsConHET 0
  
  set count-trans-by-stage n-values num-stage [0];; disease stage
  set count-trans-by-sex n-values num-sex [0]
  set count-trans-by-age n-values num-age [0]
  
  ;  1. Persons infected in past month and have multiple partners in same month
  ;The below are persons infected anywhere before the past month and during a one-month period have
  ;2. Only one partner: he/she is a main partner and is uninfected
  ;3. Only one partner: he/she is a casual partner and is uninfected
  ;4. Two main partners (no casual partners): at least one is uninfected  (we model at most 2 main partners)
  ;5. Two or more casual partners (no main partners): at least one is uninfected
  ;6. Two or more partners (at least one is main AND at least one is casual): at least one is uninfected
  set count-trans-by-partner-type [0 0 0 0 0 0 0];;main ;concurrent ; casual; needle sharing
 
  set count-person-years-by-stage n-values num-stage [0]
  set count-person-years-by-sex n-values num-sex [0]
  set count-person-years-by-age n-values num-age [0]
  
  set countNewDiagnosis [0 0 0 0 0 0]
  
  ; prevalence and sharing prevalence (not currently used as IDU-mixing is dictating the sharing behaviors)
  set prevalence n-values num-sex [0]   
  set sharing-prevalence n-values num-sex [0]
  
  set total-transmissions-quarter 0
  
  set PLWH 2
  
end

to setup-sensitive-globals
  
  set sensitive-var-name
  [
    "percent-IDU-sharing"
    "percent-needles-shared"
    "prob-ptnr-sharing"
    "percent-sharing-decline"
    "trans-rate-needle-after-dry-run"
    "trans-rate-needle-dry-run"
  ]
  ; sensitive variable values
  set base-var-val [0.25 0.085 0.25 0.9 0.0015 0.0035]
  ; % chagne in sensitivity analysis
  set sensitive-range [-1 -0.5 -0.25 0.25 0.5 1]
  set num-sensitive-range length sensitive-range
  set num-sensitive-var length sensitive-var-name
  
end

to initialize-sensitive-globals 
  
  set sensitive-var-table table:make
  let k 0
  repeat num-sensitive-var
  [
    table:put sensitive-var-table item k sensitive-var-name item k base-var-val
    set k k + 1
  ]
  
end

to assign-sensitive-globals
  
  set percent-IDU-sharing table:get sensitive-var-table "percent-IDU-sharing"
  set percent-needles-shared table:get sensitive-var-table "percent-needles-shared"
  set prob-ptnr-sharing table:get sensitive-var-table "prob-ptnr-sharing"
  set trans-rate-needle-after-dry-run table:get sensitive-var-table "trans-rate-needle-after-dry-run"
  set trans-rate-needle-dry-run table:get sensitive-var-table "trans-rate-needle-dry-run"
  set trans-rate-needle trans-rate-needle-dry-run
  set percent-sharing-decline table:get sensitive-var-table "percent-sharing-decline"
  
end

to setup-static-globals
  
  ; care continuum distribution for bucket approach
  setData
  ;;proportions in 2008
  ; set base-case-nocare 0.49 ;(proportion of those aware no care)
  ; set base-case-ART 0.35 ;(proportion of those aware on ART suppressed or unsuppressed)
  ; set base-case-unaware [0.197332107 0.249774572 0.22137931 0.136798906 0.144486692 0.122040073]; [HET-female het-male MSM IDU-female IDU-male IDU-MSM]
  ; set prop-unsuppressed 0.23 ;; proportion on ART and viral not suppressed 
   
  ;;2006 values. Parameters used in simulation. Gets overs written for years 2008 and further
  set current-unaware matrix:get-row matrix_unaware 0;[0.211700545  0.268269231  0.234774436 0.136798906 0.144486692 0.122040073]; [HET-female het-male MSM IDU-female IDU-male IDU-MSM]
  set current-no-care matrix:get-row matrix_noCare 0;0.39
  set current-care-noART matrix:get-row matrix_careNoART 0;0.16
  set current-ARTsuppressed matrix:get-row matrix_ARTVLS 0;0.19
  set actual-age-dist-incidence matrix:get-row matrix_ageDistIncidence 0
  set care-at-diag  matrix:get-row matrix_LinkageToCare 0;0.77 
  set care-at-diag-ByAge  matrix:get-row matrix_LinkageToCare_ByAge 0;0.77 
  
  ; age and CD4 upper and lower bound for reporting
  set age-LB [13 25 35 45 55]
  set age-UB [25 35 45 55 100] 
    
  set CD4-LB [0 51 201 351 501]
  set CD4-UB [50 200 350 500 2000]
  
  ; proportion of total US population in age 13 - 70
  set pop-by-age
  [
    0.0180 0.0180 ; 13-14
    0.0192 0.0192 0.0192 0.0192 0.0192 0.0188 0.0188 0.0188 0.0188 0.0188 ; 15-24
    0.0184 0.0184 0.0184 0.0184 0.0184 0.0174 0.0174 0.0174 0.0174 0.0174 ; 25-34
    0.0176 0.0176 0.0176 0.0176 0.0176 0.0182 0.0182 0.0182 0.0182 0.0182 ; 35-44
    0.0198 0.0198 0.0198 0.0198 0.0198 0.0194 0.0194 0.0194 0.0194 0.0194 ; 45-54
    0.0171 0.0171 0.0171 0.0171 0.0171 0.0146 0.0146 0.0146 0.0146 0.0146 ; 55-64
    0.0108 0.0108 0.0108 0.0108 0.0108 ; 65-69
    0.0081 ; 70
  ]
  
  ;;Number of HET-male, female and MSM in total population assuming 97% are hetrosexual and rest MSM. Of hetrosexual half are male and rest half female.
  ;;469.4 is the rate of PLWH per 100,000 US population in 2008
  set factor 0.5; assuming 50% of population is high risk
  set overall-prevalence 441 / 100000 ; 2006 overall prevalence in general population
  set perc-HET-FEM 0.5 * factor * (1 - (perc-IDU-FEM + perc-IDU-MEN + perc-MSM + perc-IDU-MSM))
  set perc-HET-MEN perc-HET-FEM
  set perc-MSM 0.025 * (1 - 0.07)
  set perc-IDU-FEM 0.012
  set perc-IDU-MEN 0.018
  set perc-IDU-MSM 0.025 * 0.07
  set num-HET-FEM (perc-HET-FEM * number-people / overall-prevalence)
  set num-HET-MEN num-HET-FEM
  set num-MSM (perc-MSM * number-people / overall-prevalence) ;; assuming 2% of US population are MSM
  set num-IDU-FEM (perc-IDU-FEM * number-people / overall-prevalence)
  set num-IDU-MEN (perc-IDU-MEN * number-people / overall-prevalence)
  set num-IDU-MSM (perc-IDU-MSM * number-people / overall-prevalence)
  ;  set num-HET-FEM (0.5 * (1 - (0.03 + 0.012 + 0.018)) * number-people * factor * 100000 / 469.4 ) 
  ;  set num-HET-MEN (0.5 * (1 - (0.03 + 0.012 + 0.018)) * number-people * factor * 100000 / 469.4) 
  ;  set num-MSM (0.03 * ( 1 - 0.02) * number-people  *  100000 / 469.4) ;; assuming 3% of US population are MSM
  ;  set num-IDU-FEM (0.012 * number-people * 100000 / 469.4)
  ;  set num-IDU-MEN (0.018 * number-people * 100000 / 469.4)
  ;  set num-IDU-MSM (0.03 * 0.02 * number-people * 100000 / 469.4)
  ;; for 2012 prevalence per 100,000 is 573;; fpr 2008 it is 470 
  
  set sex-dist-target ; 2006 distribution of PLWH by sexual risk groups
  [0.1838 0.0948 0.4849 0.0666 0.1200 0.0500]
 
  set cum-sex n-values num-sex [0] ; calculating cumulative distribution of sexual risk groups 
  let sex-ind 0
  let temp 0
  while [sex-ind < num-sex]
  [
    set temp temp + item sex-ind sex-dist-target
    set cum-sex replace-item sex-ind cum-sex temp
    set sex-ind sex-ind + 1
  ]
  
  set cum-sex replace-item (num-sex - 1) cum-sex 1 
  
  set age-group 
  [12 24 34 44 54 70]
  set actual-age-dist-PLWH 
  [0.051 0.161 0.353 0.304 0.131]

  set cum-stage 
  [
    [0.0066	0.2117	0.6059	0.7635	0.8108	1.0000]
    [0.0057	0.2683	0.6341	0.7805	0.8244	1.0000]
    [0.0068	0.2348	0.6174	0.7704	0.8163	1.0000]
    [0.0040	0.1368	0.5684	0.7410	0.7928	1.0000]
    [0.0032	0.1445	0.5722	0.7433	0.7947	1.0000]
    [0.0046	0.1220	0.5610	0.7366	0.7893	1.0000]
  ]  
  
  set cum-age1 
  [
    ;;2006 HET+MSM+IDU updated with new age group (updated with NHSS vol. 17 no.3)
    ;0.052 0.212 0.564 0.868 0.973 1
    0.001 0.041 0.211 0.361 0.511 0.661 0.781 0.891 0.956 0.996 1 1
    ;;2006 updated with new age group
    ; 0.001  0.041  0.211  0.361  0.511  0.661  0.781  0.891  0.956  0.996  1  1
    ;;2008 updated with new age group
    ;0.001  0.041  0.211  0.361  0.511  0.661  0.781  0.891  0.956  0.996  1  1
  ]
  set cum-age2 
  [
    ;; HET+MSM+IDU 2006 updated with new age group
    0.00261732 0.006823137 0.01342271 0.059541006 0.139662051 0.289628793 0.512083389 0.709279636 0.849658024 0.929011911 0.967894103 1     
    ;; HET+MSM 2006 updated with new age group
    ; 0.002650833  0.006114961  0.009328727  0.053294498  0.131967587  0.28193364  0.506511189  0.705514223  0.847454521  0.927623856  0.967228839  1
    ;; HET+MSM 2008 updated with new age group
    ;0.002627447  0.006609129  0.012185525  0.057653337  0.137336816  0.287303349  0.510399493  0.708141744  0.848992135  0.928592446  0.967693063  1
  ]
  
  set prop-unaware-new 
  [0.712898298 0.479218799 0.609813512 0.661655027 0.493277501 0.736226832]
  set prop-MSM-stage3-new 0.021174159
  set prop-MSM-stage4-new 0.052935457
  
  ;;number of main and casual partners per person per year in age group
  ;HET age range 15�17  18�19  20�24    25�29  30�34  35�39  40�44 >44 (NSFG for HETs)
  ;;MSM partners by age 18-24  25-34  35-44  45-54  55-64 (NHBS)
  ;;main partners per year 1.89  1.76  1.7  1.66  1.61
  ;; casual partners per year 13.91  20.62  24.8  22.46  25.7
  ;;min age in model is 13: using same number of partners as lowest age group available
  ;age range of below arrays for number partners 13-14 15�17  18�19  20�24  25�29  30�34  35�39  40�44 45-54  55-64 65-70
  ;
  
  ;;ADDED A LAST AGE GROUP 65- 70
  set age-partner-dist 
  [14 17 19 24 29 34 39 44 54 60 70]
  set main-partners 
  [
    [1.75 1.75 1.68 1.47 1.26 1.19 1.09 1.10 1.10 1.10 1.10] ;;NSFG HET FEmale
    [1.74 1.74 1.86 1.69 1.45 1.29 1.30 1.21 1.21 1.21 1.21] ;;NSFG HET male
    [1.74 1.74 1.86 1.69 1.45 1.29 1.30 1.21 1.21 1.21 1.21] ;;NSFG HET male
    [1.74 1.74 1.86 1.69 1.45 1.29 1.30 1.21 1.21 1.21 1.21] ;;NSFG HET male
    [1.74 1.74 1.86 1.69 1.45 1.29 1.30 1.21 1.21 1.21 1.21] ;;NSFG HET male
    [1.74 1.74 1.86 1.69 1.45 1.29 1.30 1.21 1.21 1.21 1.21] ;;NSFG HET male
  ]
  ; set concurrency-length   [1 3 6 9 12 15 18 24 36 ]
  ; set concurrency-length-prob [ 0.31  0.5  0.61  0.7  0.74  0.77  0.79  0.84  0.89] ;;>0.89 will take length of normal partnership
  set prop-concurrency 
  [0.083 0.09 0.52 0.083 0.09 0.52]; [0 0 0 0 0 0 ];
  set concurrency-lambda 
  [1.13 1.13 0.78 1.13 1.13 0.78] ;; [HET-female HET-male MSM]: above distribution of concurrence is exponential, therefore using lambda to determine length of concurrency
   ;; <= 1 months are considered casual. SInce MSM casual is modeled separately, excluding that category for MSM and re-estimating for other
;    1.89  1.89  1.89  1.89  1.76  1.76  1.7  1.7  1.66  1.61  1.61  ;;NHBS MSM
;    1.89  1.89  1.89  1.89  1.76  1.76  1.7  1.7  1.66  1.61 1.61  ;;IDU male
;    1.89  1.89  1.89  1.89  1.76  1.76  1.7  1.7  1.66  1.61 1.61  ;;IDU female
;    1.89  1.89  1.89  1.89  1.76  1.76  1.7  1.7  1.66  1.61 1.61  ;;IDU MSM
;  ]
  
  set prob-casual .56;0.66;
  set prob-casual-only .41; 0.36 ;(of 1) ;
  set prob-serosorting .15
  set reduction-unprotected-aware .53
  ;set casual-partners  ;;for MSM and IDU's only
  ;[1.8 1.8 1.8 1.8 4.4 4.4 4.4 4.4 4.4 2.6 2.6 ;;lower 95% CI
  ;  4.1 4.1 4.1 4.1 5.8 5.8 5.8 5.8 5.8 5.4 5.4  ;;upper 95% CI
    ;2.8 2.8 2.8 2.8 5.0 5.0 5.0 5.0 5.0 4.0 4.0 ; median
  ;]
  
;  set casual-partners  [0 0 0 0 0 0 0 0 0 0  0
;    0 0 0 0 0 0 0 0 0 0  0
;    13.91  13.91  13.91  13.91  20.62  20.62  24.8  24.8  22.46  25.7  0;;NHBS MSM
;    13.91  13.91  13.91  13.91  20.62  20.62  24.8  24.8  22.46  25.7  0
;    13.91  13.91  13.91  13.91  20.62  20.62  24.8  24.8  22.46  25.7  0
;    13.91  13.91  13.91  13.91  20.62  20.62  24.8  24.8  22.46  25.7  0
;  ] 
  
;  set prop-low-risk-MSM [
;     0.05  0.05  0.05  0.05  0.05  0.15   0.15  0.28  0.28  0.28  0.28 ;;proportion having only 1 casual partner per year (columns are age group)
;     0.20 0.20 0.20 0.20  0.30  0.70   0.70 0.56  0.56  0.56  0.56  ;; proportion having 2-3 casual partners per year (columns are age group)
;  ]
  
;    age group  18-24  25-29  30-39  >=40
;# casual partners  1  5  5  15  28
;  2 to 3  15  25  55  28
;  >=4  80  70  30  44
 
  ;;rows represent female, male, MSM, IDU-female, IDU-male, IDU-MSM
  set no-partners 
  [
    ;;monthly
    [0.84 0.84 0.83 0.78 0.79 0.78 0.80 0.82 0.82 0.82 0.82 0.82 0.82]
    [0.87 0.87 0.84 0.80 0.79 0.78 0.79 0.82 0.82 0.82 0.82 0.82 0.82]
    [0.87 0.87 0.84 0.80 0.79 0.78 0.79 0.82 0.82 0.82 0.82 0.82 0.82]
    [0.87 0.87 0.84 0.80 0.79 0.78 0.79 0.82 0.82 0.82 0.82 0.82 0.82]
    [0.87 0.87 0.84 0.80 0.79 0.78 0.79 0.82 0.82 0.82 0.82 0.82 0.82]
    [0.87 0.87 0.84 0.80 0.79 0.78 0.79 0.82 0.82 0.82 0.82 0.82 0.82]
    ;;yearly
    ; [0.13 0.13 0.10 0.05 0.06 0.05 0.07 0.09 0.09 0.09 0.09];;NSFG HET FEmale
    ; [0.18 0.18 0.12 0.07 0.06 0.05 0.06 0.09 0.09 0.09 0.09];;NSFG HET male
    ; [0.18 0.18 0.12 0.07 0.06 0.05 0.06 0.09 0.09 0.09 0.09];;NSFG HET male
    ; [0.18 0.18 0.12 0.07 0.06 0.05 0.06 0.09 0.09 0.09 0.09];;NSFG HET male
    ; [0.18 0.18 0.12 0.07 0.06 0.05 0.06 0.09 0.09 0.09 0.09];;NSFG HET male
    ; [0.18 0.18 0.12 0.07 0.06 0.05 0.06 0.09 0.09 0.09 0.09];;NSFG HET male
  ]    
  ;0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1] 
  
  set age-sex-acts 
  [18 20 25 30 40 50 60 70]
  set num-sex-acts-upper 
  [
    41 127 127 108 93 86 73 62 ;; female NSSHBS
    60 119 119 110 104 95 73 67  ;;male  NSSHBS ;; applying this to MSM and IDU's as well
  ]
  set num-sex-acts-lower 
  [
    20 73 62 51 48 40 32 35;;female NSSHBS
    30 68 63 59 52 39 36 24;;male NSSHBS ;; applying this to MSM and IDU's as well
  ]
  
  ;;for heterosexual IDU and non-IDU
  set  prop-anal-acts-HET 
  [
    0.07 0.07 0.07 0.08 0.06 0.04 0.02 0.04;;female
    0.06 0.06 0.06 0.11 0.07 0.09 0.06 0.05;;male
  ]
  ;;for MSM 50% insertive and 50% receptive anal sex
  
  set prob-bisexual .21
  set condom .8
  ;;for heterosexual IDU and non-IDU
  set age-condom-use-MSM 
  [18 20 25 30 40 50 60 70] ;; asssuming maximum age 70
  set condom-use-HET 
  [
    0.58 0.39 0.39 0.27 0.18 0.14 0.11 0.09  ;;female
    0.79 0.45 0.45 0.28 0.26 0.21 0.10 0.06  ;;male 
    0.57 0.57 0.57 0.54 0.54 0.53 0.52 0.52; casual partner (taking from casual for NHBS MSM);; as of now no casaul partners for HET non-IDU's
   ;0.87 0.39 0.47 0.44 0.28 0.26 0.25    ;;NSSHB casual partners
  ]
  
  ;;numbers from NHBS: on last sex act
  ;;for MSM IDU and non-IDU
  set condom-use-MSM 
  [
    0.79 0.45 0.45 0.28 0.26 0.21 0.10 0.06  ;;taking from NSSHB HET
   ;0.38 0.38 0.35 0.32 0.35 0.34 0.41 0.41 ;; NHBS main
    0.57 0.57 0.57 0.54 0.54 0.53 0.52 0.52 ;; NHBS casual partner 
  ]
  set condom-100perc 0.18;; proportion of MSM individuals using condoms  100% of time  

 ;set initial-infection-percent 100
  
  ;;Number of quarters of life remaining starting from age 10 to 100
  ;set define-non-AIDS-death 
  ;[273  269  266  262  258  254  250  246  242  238  
  ; 234  231  227  223  219  216  212  208  204  200  
  ; 197  193  189  185  181  178  174  170  166  163  
  ; 159  155  152  148  144  141  137  133  130  126  
  ; 123  119  116  113  109  106  103  99  96  93  89  
  ; 86  83  80  77  74  71  68  65  62  59  57  54  51  
  ; 49  46  44  41  39  37  35  33  31  29  27  26  24  
  ; 22  21  20  18  17  16  15  14  13  12  11  10  10  9]
  ;;Number of MONTHS life remaining starting from age 10 to 100
  set define-non-AIDS-death 
  [
    819 807 798 786 774 762 750 738 726 714 ; 10-19
    702 693 681 669 657 648 636 624 612 600 ; 20-29
    591 579 567 555 543 534 522 510 498 489 ; 30-39
    477 465 456 444 432 423 411 399 390 378 ; 40-49
    369 357 348 339 327 318 309 297 288 279 ; 50-59
    267 258 249 240 231 222 213 204 195 186 ; 60-69
    177 171 162 153 147 138 132 123 117 111 ; 70-79
    105  99  93  87  81  78  72  66  63  60 ; 80-89
    54  51  48  45  42  39  36  33  30  30 ; 90-99
    27 ; 100
  ]
  ;set non-AIDS-death item (min-age - 10) define-non-AIDS-death
  ;print non-AIDS-death
  set discount-rate 0.03
  
  ;testing
  set freq-MSM 1
  set freq-HET 5
  set freq-at-least-once 2
  set freq-no-test 10
  set prob-compliance 0.4
  set prob-no-test 0.1
  
  ;;Unit of measure for belo viral load values is log10 copies/ml
  
  set viral-load-by-stage-mean 
  [5.3 4.5 4.5 4.5 3.7 1.3]
  set viral-load-by-stage-lb 
  [4.4 4.0 4.0 4.0 3.1 1.0]
  set viral-load-by-stage-ub 
  [6.2 5.0 5.0 5.0 4.5 2.7]
  set viral-load-by-stage-std 
  [0.459 0.255 0.255 0.255 0.357 0.434]  
  set viral-load-salvage-add-mean 0.8 ;; additional viral load above set-point when no AIDS
  set viral-load-salvage-AIDS-add-mean 1 ;; additional viral load above set-point when no AIDS
  set viral-load-salvage-add-lb 0 
  set viral-load-salvage-AIDS-add-lb 0
  set viral-load-salvage-add-ub 1.5
  set viral-load-salvage-AIDS-add-ub 2.0
  set viral-load-salvage-add-std 0.383
  
  ;;CD4 declines based on vairal load: lower bound of viral load (copies/ml) for CD4-decline-per-quarter: 0 501 2001 3,001 10,001 30,001 40,000 
  ;set CD4-decline-per-quarter [-5.10 -9.90 -12.00 -12.00 -14.10 -14.10 -19.50]
  ;CD4-decline-per-month
  set CD4-decline 
  [-1.7 -3.3 -4 -4 -4.7 -4.7 -6.5]
  set CD4-decline-upper-bound-month 
  [-0.8 -2.4 -3.3 -3.3 -3.9 -3.9 -5.7]
  set CD4-decline-lower-bound-month 
  [-2.6 -4.1 -4.6 -4.6 -5.4 -5.4 -7.3]
  set CD4-decline-std-month 
  [0.46 0.43 0.33 0.33 0.38 0.38 0.41]
  set CD4-decline-quarter 14.1
  ;; Increases in CD4 count after ART
  set CD4-increment-1 (68 / 3)* 12 / time-unit;; CD4-increment-for quarter 1-2 is 68 per quarter
  set CD4-increment-2 (40 / 3) * 12 / time-unit ;; CD4-increment-for quarter 3-12
  set CD4-increment-3 0 ;; CD4-increment-for quarter 12+
  set CD4-max-levels 
  [870 780 660 548 410] ; for baseline CD4 counts , i.e., counts at start of tretament at >500 >350 >200 > 50 <50
  
  set CD4-upper-new-infection 
  [900 880.5 880.5 880.5]
  set CD4-lower-new-infection 
  [750 576 725 725]
  set unaware-CD4-upper 
  [200 500 725]
  set unaware-CD4-lower 
  [36 201 501]
  set unaware-CD4-prob 
  [0.24 0.4]
  set awareNoCare-CD4-upper 725
  set awareNoCare-CD4-lower 101
  set inCareNoART-CD4-upper 
  [500 600 725]
  set inCareNoART-CD4-lower 
  [350 501 601]
  set inCareNoART-CD4-prob 
  [0.10 0.80]
  set ART-CD4-lower 550 
  set ART-CD4-upper 800
  set CD4-at-ART-lower 
  [36 201 351]
  set CD4-at-ART-upper 
  [200 350 500]
  set CD4-at-ART-prob 
  [0.3 0.9]
  
  set CD4-start-ART-guideline1 350
  set CD4-start-ART-guideline2 500
  set CD4-start-ART-guideline3 1000
  set CD4-start-ART-guideline CD4-start-ART-guideline1
  
  set CD4-count-stratum 
  [0 50 100 200 300 500];; lower bound of CD4 count to determin CD4 stratum each quarter
  
  set prop-CD4-diagnosis-500 
  [0.9 0.9 0.75 0.9 0.9 0.75];;proportion diagnosing below 500 (used for indexpatients only)
  set prob-CD4-diagnosis-200 0.24
  set prob-CD4-diagnosis-50 0.43
  set prob-CD4-at-care-200 0.9
   
  set initial-drop-out 0.5
  set rebound-duration 3 * time-unit / 12; one quarter for viral load rebound
  set viral-rebound-rate 
  [0.05 0.025 0.018 0.015 0.014]
  set viral-rebound-CD4-upper 
  [100 200 300 400 1000]
  set viral-rebound-CD4-lower 
  [0 100 200 300 400 1000]
  set viral-rebound-increase 0.18
  set probability-initial-suppression 
  [0.774 0.79 0.84] ;stratified by CD4 count at ART <=50  50-200  >200 ;; [0.8 0.8 0.8] 
  set prob-reEnter 0.45
  set num-regimen 4

  ;;Regimen  cost per quarter in  regimen = 0  1  2  3  4  10  40
  ;set regimen-cost [0  3490  4858  4677  0 7403  0] ;; from Gebo et. al., AIDS 2010
  ;;Regimen  cost per month in  regimen = 0  1  2  3  4  10  40
  ;;NOTE: When num-regimen above is set to 3 the 4th regimen cost is not going to apply anywhere.
  set regimen-cost 
  [0 1163 1619 1559 0 2468 0]
  
 ; One time cost of testing for HIV
  if goal = 1
  [set cost-testing 14845;
  set retention-care-cost 0;
  ]
  if goal = 2 
  [set cost-testing 16145 ;;(increased testing );;14845;
   set retention-care-cost 0;
  ]  
  if goal = 3 
  [set cost-testing 14845 
  set retention-care-cost  817 / 12 ;0;( assuming services given once per year. Split cost into monthly)
  ]
  if goal = 4 
  [set cost-testing 14845 + 817 ;;(testing + linkgae to care);;14845;
  set retention-care-cost  0 
  ]
  if goal = 5 
  [set cost-testing 16145 + 817 ;;(testing + linkgae to care);;14845;
  set retention-care-cost 817 / 12 ;0;( assuming services given once per year. Split cost into monthly)
  ]  
  ;; in 2010 dollars of (14845 in 2010$ from Ram Shrestha's expanded testing expenditure paper for base case and 16145 for NHAS goal + 817 for ARTAS linkage to care);;
 ;  set cost-testing 2497;; from PATH 1 ED; 
  
  set max-ptnr 10
  set num-needles-max 500
  set num-needles-min 100
  set reduction-aware-needles -0.0675
  set reduction-noART-needles 0.08
  set reduction-ART-needles 0.12
  set reduction-VLS-needle-trans-rate 0.76
  
  set IDU-mixing 
  [
    [0 0 0 0 0 0]
    [0 0 0 0 0 0]
    [0 0 0 0 0 0]
    [0 0 0 0.30 0.47 0.23]
    [0 0 0 0.30 0.47 0.23]
    [0 0 0 0.30 0.47 0.23]
  ]
  
  set-OI-probabilities 
  
  ;;Annual probabilities of dying when NOT on ART 
  ;startified by current CD4 0-40 50-199 200-349 350-499 500-649 >=650
  set death-rate-no-ART-sexual 
  [0.201 0.0308 0.0058 0.0032 0.002 0.0017]
  ;;startified by current CD4 0-199 200-349 >=350
  set death-rate-no-ART-idu 
  [0.1661 0.0599 0.043]
   
  ;;Probabilities of dying when on ART. Startified by age and CD4 count at start of ART
  ;;5- year probability *100 of survival
  set death-prob-sexual-no-AIDS 
  [
    [5.0 4.1 4.1 3.4 2.5 1.8]
    [6.3 5.2 5.2 4.3 3.1 2.3]
    [8.3 6.9 6.9 5.7 4.1 3.0]
    [15.0 13.0 13.0 11.0 7.7 5.6]
  ]
  set death-prob-sexual-AIDS 
  [
    [10.0 8.7 8.6 7.2 5.2 3.8]
    [13.0 11.0 11.0 9.0 6.5 4.8]
    [17.0 14.0 14.0 12.0 8.6 6.3]
    [30.0 25.0 25.0 21.0 16.0 12.0]
  ]
  set death-prob-idu-no-AIDS 
  [
    [14.0 12.0 12.0 10.0 7.3 5.3]
    [18.0 15.0 15.0 12.0 9.1 6.7]
    [23.0 19.0 19.0 16.0 12.0 8.8]
    [39.0 33.0 33.0 28.0 21.0 16.0]
  ]
  set death-prob-idu-AIDS 
  [
    [28.0 24.0 24.0 20.0 15.0 11.0]
    [34.0 29.0 29.0 25.0 18.0 14.0]
    [43.0 37.0 37.0 31.0 24.0 18.0]
    [65.0 58.0 58.0 51.0 40.0 31.0]
  ]
   
  ;  Source:  A prognostic model for clinical progression up to five years after initiation of highly active antiretroviral therapy                
  ;    The Antiretroviral Therapy (ART) Cohort Collaboration*                
  ;    *All members of study groups are listed at end of paper                
  ;    VERSION 15/5/06                
  ;    SUPPLEMENTARY TABLES                
  ;    Please see published paper AIDS 2007 21: 1185-1197                
  ;                    
  ;                    
  ;                    
  ;From ART Cohort Collaboration      5 year probability of survival after initation of HAART              
  ;                               age <25  25-49  50-99  100-199  200-349  > 350
  ;                    
  ;  NO IDU    No clinical AIDS   0     5  4.1  4.1  3.4  2.5  1.8
  ;                              30     6.3  5.2  5.2  4.3  3.1  2.3
  ;                              40     8.3  6.9  6.9  5.7  4.1  3
  ;                              50     15  13  13  11  7.7  5.6
  ;      Clinical AIDS              
  ;                              0      10  8.7  8.6  7.2  5.2  3.8
  ;                               30    13  11  11  9  6.5  4.8
  ;                              40     17  14  14  12  8.6  6.3
  ;                               50    30  25  25  21  16  12
  ;                    
  ;  IDU    No clinical AIDS     0      14  12  12  10  7.3  5.3
  ;                              30     18  15  15  12  9.1  6.7
  ;                              40     23  19  19  16  12  8.8
  ;                              50     39  33  33  28  21  16
  ;                    
  ;      Clinical AIDS            0     28  24  24  20  15  11
  ;                              30     34  29  29  25  18  14
  ;                              40     43  37  37  31  24  18
  ;                              50     65  58  58  51  40  31
  
  ; average partners per year
  ;set trans-rate-female 0.0008;0.0004
  ;set trans-rate-male 0.0008;0.0008
  ;set trans-rate-MSM-receptive 0.0018   ;;0.007
  ;set trans-rate-MSM-insertive 0.0082;; .014
  
  
  ;;transmission probabilities: columns represent risk type of positive  person [female male MSM IDUfemale IDUmale IDUMSM]
  
  set-trans-rate-stage
  
  ;Quarterly rates  of HIV transmission for incidence by prevalence analysis
  ;set saa 0.1834
  ;set sau 0.1834
  ;set snu  0.0226
  ;set snan  0.0097
  ;set snatn  0.0097
  ;set snats  0.0010
  ;  
  ;set iaa  0.3343
  ;set iau  0.3343
  ;set inu  0.0413
  ;set inan  0.0177
  ;set inatn  0.0177
  ;set inats  0.0018
  ;Quarterly rates  of HIV transmission                      
  ;0.1834  0.1834  0.0226  0.0097  0.0097  0.0010    0.3343  0.3343  0.0413  0.0177  0.0177  0.0018
  ;saa  sau  snu  snan  snatn  snats    iaa  iau  inu  inan  inatn  inats
  
  
  ;;Costs on 2010 dollars
  ;;OI prophylaxis + inpatient + outpatient + ED costs: incurred from start of care for HIV
  ;;quaterly
  ;set HIV-utilization-cost [ 6024  2667  1271  860  697] ;; startified by CD4 count lower bound[ 0 51 201 351 501]
  ;;monthly
  set HIV-utilization-cost 
  [2008 889 424 287 232]
  
  ;; non-HIV medication costs : incurredd from time of infection 
  ;quaterly
  ;set non-HIV-med-cost [583  566  523  532  594 ] ;; startified by CD4 count defined in CD4-count-stratum above 
  ; monthly
  set non-HIV-med-cost 
  [194 189 174 177 198] 
  
  ;quaterly
  ;set std-not-in-care-cost [49    29      22    21    20] ;;standard deviation non-HIV-med-cost
  ;monthly
  set std-not-in-care-cost 
  [17 10 8 7 7]
  
  ;quaterly
  ;set std-in-care-cost [467    171      92    54    41];; standard deviation non-HIV-med-cost + OI prophylaxis + inpatient + outpatient + ED 
  ;monthly
  set std-in-care-cost 
  [161 59 32 19 14]
  ;;one time costs of OI at quarter of occurence: 
  ;;OI-type:   PCP  MAC  Toxoplasmosis  Cytomegalovirus  Fungal infection  Other
  ;;;OI-type index    1  2  3  4  5  6
  set OI-cost 
  [9044 3611 21243 5620 6154 4121]
  
  set CD4+rna-test-cost 148 ;; test used every quarter 
  set HIV-genotype-test-cost 439 ;; one time cost at beginning of new regimen 
  
  ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
  ;;Collecting population information
  ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
  set population-time-on-salvage 0
  set population-time-on-ART 0
  set population-life-with-infection  0
  
  set zero-on-salvage 0
  set population-no-life-lost-from-infection 0
  set population-die-from-CD4-zero 0
  
  ; set discount-life-if-no-HIV 0
  ; set-discount-life-if-no-HIV     
  
end


to set-OI-probabilities 
  ;;monthly risk of OI
  let risk  
  [
    [0.00000 0.00000 0.00000 0.00000 0.00000 0.00000]
    [0.03700 0.03100 0.00960 0.00373 0.00085 0.00041]
    [0.01220 0.00375 0.00101 0.00022 0.00006 0.00006]
    [0.00270 0.00140 0.00067 0.00042 0.00009 0.00003]
    [0.01857 0.00523 0.00214 0.00058 0.00013 0.00006]
    [0.01123 0.00591 0.00135 0.00029 0.00028 0.00009]
    [0.03940 0.02460 0.00716 0.00224 0.00087 0.00047]
  ]
  set OI-probabilities n-values 7 [n-values num-stage [0]]

  ;;converting risk to probabilities per tim-unit
  let i  0
  while [i < 6]
  [let j  0
    while [j < 7]
    [let val item i (item j risk) 
      set OI-probabilities (replace-item j OI-probabilities (replace-item i (item j OI-probabilities) (1 - exp(- val * 12 / time-unit))))
      set j j + 1
    ]
    set i i + 1    
  ]  
  
  set i 0
  while [i < 6]
  [let j  1
    while [j < 7]
    [let val item i (item j OI-probabilities) 
      let val2 item i (item (j - 1) OI-probabilities)
      set OI-probabilities (replace-item j OI-probabilities (replace-item i (item j OI-probabilities) (val + val2)))
      set j j + 1
    ]
    set i i + 1
  ]  
  
  ;Cumulative probability of developing Opportunistic Infections (OIs) based on CD4 count (CD stratum) - QUARTERLY (assume one OI per period)          oii, oi1-oi6    
  ;OI index  Description  0-50 (1)  51-100 (2)  101-200 (3)  201-300 (4)  301-500 (5)  >500 (6)
  ;1         PCP           0.0000  0.0000  0.0000  0.0000  0.0000  0.0000
  ;2         MAC           0.1069  0.0901  0.0285  0.0111  0.0025  0.0012
  ;3  Toxoplasmosis        0.1431  0.1014  0.0316  0.0118  0.0027  0.0014
  ;4  Cytomegalovirus      0.1512  0.1055  0.0336  0.0131  0.0030  0.0015
  ;5  Fungal infection     0.2059  0.1212  0.0400  0.0148  0.0034  0.0017
  ;6        Other          0.2392  0.1388  0.0440  0.0157  0.0042  0.0019
  ;0        None           0.3528  0.2108  0.0653  0.0224  0.0068  0.0033
  
end

to set-trans-rate-stage
  ;;transmission probabilities: columns represent risk type of positive  person [female male MSM IDUfemale IDUmale IDUMSM] first 6 for vaginal sex 7-12 for anal sex
  ;;rows represent disease stage of person
  set trans-rate-prob 
  [
    0.0008 0.0008 0.002 0.0008 0.0008 0.0018  ;; vaginal sex probabilities;; 0.0008  0.0008 0.0018  0.0008  0.0008 0.0018
    0.0018 0.0082 0.009 0.0018 0.0082 0.0082
  ];; anal sex probabilities   
  ;set trans-rate-prob map [i ->  i] trans-rate-prob
  ;set trans-rate-needle trans-rate-needle
  set reduction-VLS-trans-rate 0.99
  set acute-rate-increase-base 8.1
  set acute-rate-increase-week 
  [8.1 8.1 8.1 8.1 8.1 8.1 8.1 6.75 5.4 4.05 2.7 1.35]
  set acute-rate-increase-week-MSM 
  [12.0 12.0 12.0 12.0 11.4 9.2 5.8 1.5 1.0 1.0 1.0 1.0]
  set acute-rate-increase-week-HET 
  [1.0 6.0 8.5 8.5 8.1 6.5 4.1 1.1 1.0 1.0 1.0 1.0]
 
  set trans-rate-prob-stage n-values num-stage [n-values (num-sex * 2) [0]]
  ;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;  
  let i 0
  ;;acute stage values
  while [i < length (trans-rate-prob)]
  [
    set trans-rate-prob-stage (replace-item 0 trans-rate-prob-stage (replace-item i (item 0 trans-rate-prob-stage) ((item i trans-rate-prob) * acute-rate-increase-base))) ;; or 8.1%
    set i i + 1
  ]
  ;;;;;;;;;;;;;;;;;;;;;;;
  
  let j 1
  while [j < 5]
  [
    set i 0    
    ;;acute stage values
    while [i < length (trans-rate-prob)]
    [
      set trans-rate-prob-stage (replace-item j trans-rate-prob-stage (replace-item i (item j trans-rate-prob-stage) (item i trans-rate-prob)))
      set i i + 1
    ]
    set j j + 1
  ]
  ;;;;;;;;;;;;;;;;;;;;;;;;;
  
  set i 0
  ;;VLS stage values
  while [i < length (trans-rate-prob)]
  [
    set trans-rate-prob-stage (replace-item 5 trans-rate-prob-stage (replace-item i (item 5 trans-rate-prob-stage) ((item i trans-rate-prob) * (1 - reduction-VLS-trans-rate))));; original 0.9
    set i i + 1
  ]  
  
end